Live Breaking News & Updates on Erick Rowinsky|Page 6

Stay updated with breaking news from Erick rowinsky. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Wedbush Boosts Biogen (NASDAQ:BIIB) Price Target to $215.00

Biogen (NASDAQ:BIIB – Free Report) had its target price upped by Wedbush from $213.00 to $215.00 in a report published on Thursday morning, Benzinga reports. They currently have a neutral rating on the biotechnology company’s stock. Wedbush also issued estimates for Biogen’s Q2 2024 earnings at $3.43 EPS, Q4 2024 earnings at $4.30 EPS, FY2024 […] ....

United States , Erick Rowinsky , America Bofa , William Blair , Priya Singhal , Partners Investment Advisory , Sequoia Financial Advisors , Stratos Wealth Partners , Needham Company , Financial Group , Biogen Inc , Ballentine Partners , Free Report , Moderate Buy , Get Free Report , Director Eric , Wealth Partners , Financial Advisors , Street Partners Investment Advisory , Biogen Daily ,

Barclays Trims Biogen (NASDAQ:BIIB) Target Price to $200.00

Biogen (NASDAQ:BIIB – Free Report) had its target price trimmed by Barclays from $215.00 to $200.00 in a report published on Thursday morning, Benzinga reports. They currently have an equal weight rating on the biotechnology company’s stock. BIIB has been the topic of several other research reports. Wedbush upped their target price on Biogen from […] ....

United States , Erick Rowinsky , Priya Singhal , Vanguard Group Inc , Canaccord Genuity Group , First Trust Advisors , International Assets Investment Management , Biogen Inc , Norges Bank , Free Report , Moderate Buy , Get Free Report , Director Eric , Trust Advisors , Assets Investment Management , Biogen Daily , Nasdaq Biib , Lower Price Target , Barclays Plc ,

Gitterman Wealth Management LLC Purchases New Shares in Biogen Inc. (NASDAQ:BIIB)

Gitterman Wealth Management LLC purchased a new stake in Biogen Inc. (NASDAQ:BIIB – Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 980 shares of the biotechnology company’s stock, valued at approximately $254,000. Other institutional investors have also added to or reduced […] ....

United States , William Blair , Priya Singhal , Erick Rowinsky , Piper Sandler , Kb Financial Partners , Family Office , Exchange Commission , Gitterman Wealth Management , Biogen Inc , Royal Bank , Free Report , Asset Management , Capital Management , Baker Avenue Asset Management , Avenue Asset Management , Get Free Report , Director Eric , Visit Holdingschannel , Biogen Daily , Nasdaq Biib , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

Intellectus Partners LLC Cuts Stock Position in Biogen Inc. (NASDAQ:BIIB)

Intellectus Partners LLC lessened its stake in Biogen Inc. (NASDAQ:BIIB – Free Report) by 0.9% in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 5,563 shares of the biotechnology company’s stock after selling 50 shares during the quarter. Intellectus Partners LLC’s holdings in Biogen […] ....

United States , New Zealand General , New Zealand , Erick Rowinsky , Priya Singhal , Needham Company , Biogen Inc , Wellington Management Group , Intellectus Partners , Canaccord Genuity Group , Associates Corp , Northern Trust Corp , Invesco Ltd , Morgan Stanley , Cantor Fitzgerald , Free Report , Management Group , Trust Corp , Director Eric , Get Free Report , Biogen Daily , Nasdaq Biib , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,